SANTA MONICA, Calif. & TOKYO--(BUSINESS WIRE)-- Kite, a Gilead Company, and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that YESCARTA® (axicabtagene ciloleucel), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback